Innovation Capital

Fabrico is a cloud-based CMMS that manages all maintenance activities in a manufacturing facility by combining lean end-to-end maintenance methodologies. Everything required to digitalize all maintenance procedures in your plant is included in the solution. Fabrico offers preventive and reactive maintenance solutions, as well as an efficient ticketing system that allows for entire communication and compliance processes in a single plant.

GeoSpock is a developer of a cloud-native analytics database designed for handling geospatial big data and complex real-world analytics. Its primary product, GeoSpock DB, facilitates the fusion of various Internet of Things (IoT) data sources, allowing users to unlock the full value of their data while minimizing complexity and costs. The platform supports efficient data storage and rapid access, enabling users to execute ANSI SQL queries and connect seamlessly with standard analytics tools through flexible JDBC/ODBC connectors. It offers compatibility with popular business intelligence tools like Tableau, Amazon QuickSight, and Microsoft Power BI, as well as data science environments such as Python Notebooks and Apache Spark. GeoSpock DB can also be integrated with proprietary applications and internal tools, supporting open-source visualization libraries like Kepler and Cesium.js, thereby enhancing data analysis and insight sharing for its clients.

Wandercraft specializes in the development and sale of advanced exoskeletons that enable individuals with mobility impairments to walk independently. Its flagship product, Atalante, is the first exoskeleton designed for self-balanced walking, providing a realistic gait without the need for crutches or other aids. Since receiving CE-mark approval in 2019, Atalante has been utilized in European rehabilitation hospitals to assist with gait re-learning therapies. The company is also pursuing FDA approval for its technology. Additionally, Wandercraft is working on a more compact and agile Personal Mobility exoskeleton intended for everyday use. By integrating expertise in algorithmics, artificial intelligence, robotics, and clinical applications, Wandercraft aims to create innovative solutions that enhance the autonomy and quality of life for individuals with mobility challenges.

BioSerenity is a company focused on enhancing the understanding and treatment of epilepsy and other chronic diseases through innovative, digitally connected devices. These devices facilitate the retrieval and interpretation of electrophysiological signals, including electroencephalograms, electrocardiograms, and polysomnography. By enabling continuous remote monitoring of patients' health data, BioSerenity aims to optimize patient pathways in cardiology, neurology, and sleep disorders. The company also collaborates with the scientific community by providing anonymized data to researchers at the Institut du Cerveau et de la Moelle épinière (ICM), thereby contributing to advancements in epilepsy research and improving future diagnostic methods.

OpenHealth specializes in the real-time processing of health consumption data, offering a platform that collects and analyzes health information from various sources, including pharmacies and outpatient medical settings. By transforming this data into actionable insights, OpenHealth aims to support health authorities, industry stakeholders, researchers, and the public with valuable marketing and clinical research information. The company's approach enables informed decision-making in healthcare, contributing to improved health outcomes and enhanced understanding of health trends.

Ekinops is a company that specializes in next-generation optical transport solutions aimed at service providers and private networks globally. It offers a range of carrier-grade products, including the EKINOPS 360 platform, which is designed for metro, regional, and long-haul applications. Ekinops leverages its expertise in 10G, 100G, and 200G transmission technologies to enhance data transport capacity over various networks, including dark fiber, CWDM, DWDM, and SONET/SDH. Its solutions are engineered to optimize optical networks, enabling operators to efficiently manage data transmission and aggregation while ensuring high reliability through advanced Forward Error Correction capabilities.

Manufacturer and designer of contactless technology intended to serve across the world. The company offers contactless cards, tickets, RFID tags, inlays, readers and couplers for public transport, access control, object and people identification, payment and electronic documents such as e-driving licenses, e-identity cards, electronic and biometric passports thereby providing travelers with mobility and identification.

Kayentis is a global leader in electronic clinical outcome assessment (eCOA) and decentralized clinical trial solutions, dedicated to enhancing data collection processes in clinical trials for the pharmaceutical, biotech, and contract research organization sectors. Founded in 2005, the company has developed expertise in eCOA solutions applicable across all phases of clinical development, addressing over 200 indications in more than 20 therapeutic areas. To meet the evolving demands of clinical research, Kayentis offers a comprehensive suite of services that prioritize scientific integrity and patient-centric approaches. With operational capabilities spanning the USA, Europe, and Asia, the company's technology facilitates electronic data capture, providing a versatile range of tools designed to simplify data collection for both patients and clinical trial sites.

H4D, founded in 2008, is dedicated to overcoming barriers to healthcare access, whether they stem from geographic isolation or social circumstances. The company focuses on providing preventive care and managing chronic diseases through innovative telemedicine solutions. Its global telemedicine software connects patients with healthcare professionals, particularly targeting individuals in underserved areas, employees in corporate settings, seniors in group housing, and students who require medical assistance. H4D aims to make health checks accessible to all, ensuring that healthcare solutions are integrated into comprehensive health plans and supported by communication with local healthcare stakeholders. Through its commitment to inclusivity and collaboration with medical professionals, H4D strives to enhance healthcare accessibility and improve health outcomes for diverse populations.

Biomodex is a medical technology company located in Paris and Boston that specializes in creating 3D-printed anatomical models derived from medical images. These tissue-like anatomical twins are designed for patient-specific rehearsal and advanced training for physicians. By integrating biomechanical and imaging properties with fluid dynamics, Biomodex's technology enhances the surgical preparation process. The anatomically accurate models provide critical tactile feedback, which, when combined with simulated blood flow stations, offers a comprehensive training experience for medical professionals. This approach aims to increase physician preparedness and confidence, ultimately reducing the risk of surgical errors and lowering medical costs.

Expway SA specializes in wireless multicast solutions for network operators, mobile carriers, device manufacturers, and application developers globally. The company offers a range of products including Expway Middleware, which enables devices to access LTE broadcast for streaming videos and live events, and the Expway Broadcast Multicast Service Center, a server designed for efficient delivery of high-quality content to numerous subscribers simultaneously. Additionally, Expway provides the Broadcast Provisioning Manager for managing LTE broadcasting services, various eMBMS platforms for proof-of-concept and evaluation, and testing solutions for eMBMS devices. Founded in 2000 and headquartered in Paris, France, Expway has expanded its presence with offices in North America, South Korea, Japan, and China, positioning itself as a leader in the rapidly growing market for mobile broadcast and multicast services.

Wandercraft specializes in the development and sale of advanced exoskeletons that enable individuals with mobility impairments to walk independently. Its flagship product, Atalante, is the first exoskeleton designed for self-balanced walking, providing a realistic gait without the need for crutches or other aids. Since receiving CE-mark approval in 2019, Atalante has been utilized in European rehabilitation hospitals to assist with gait re-learning therapies. The company is also pursuing FDA approval for its technology. Additionally, Wandercraft is working on a more compact and agile Personal Mobility exoskeleton intended for everyday use. By integrating expertise in algorithmics, artificial intelligence, robotics, and clinical applications, Wandercraft aims to create innovative solutions that enhance the autonomy and quality of life for individuals with mobility challenges.

Crocus Technology SA specializes in magnetic random access memory products and technologies tailored for the semiconductor and electronic systems industries. The company develops magnetic sensors and embedded memory technology that facilitate efficient sensor data gathering and processing. Its products are designed for diverse applications, including telecommunications, networking, storage, computing, and handheld devices. Crocus Technology's innovative solutions enable fast read and write operations while maintaining a compact footprint, which enhances chip performance and security for devices such as smart cards, mobile phones, and data servers. By focusing on high sensitivity, stable temperature performance, and low power consumption, the company aims to improve productivity for its clients across various sectors.

Zesty Limited is a digital health company based in London, United Kingdom, that offers on-demand access to healthcare appointments through various digital platforms, including desktop, tablet, and mobile applications. Established in 2012, Zesty provides a range of tools designed for healthcare providers, enabling them to book and manage appointments, read letters digitally, and share electronic medical records. The company serves a diverse clientele, including hospitals, community providers, and general practice surgeries, which pay an annual subscription fee or a fee based on patient usage. Zesty aims to enhance the healthcare experience by streamlining tasks such as appointment booking and prescription management, ultimately working towards the creation of a fully transactional Personal Health Record that places patients at the center of their care.

FittingBox, founded in 2006 by cousins Ariel Choukroun and Benjamin Hakoun, aims to enhance the eyewear shopping experience through innovative technology. The company has developed a virtual try-on solution that allows users to try on glasses in augmented reality, addressing the common challenge of visualizing how eyewear looks before making a purchase. By offering digital content that includes three-dimensional compression and face detection, FittingBox provides an interactive platform for eyecare professionals, helping customers find frames that complement their body type and personal style. This technology not only improves the customer experience but also supports businesses in the eyewear industry by streamlining the selection process.

Voluntis, Inc. is a healthcare software company headquartered in Cambridge, Massachusetts, that specializes in developing digital therapeutic solutions for various medical conditions, including diabetes and oncology. Founded in 2001, Voluntis provides innovative tools such as Insulia, which offers personalized insulin dose recommendations for type 2 diabetes patients, and Diabeo, designed for type 1 and type 2 patients on basal-bolus insulin regimens. These solutions utilize algorithmic calculations tailored to individual patient needs, incorporating real-time data like blood glucose levels. The company aims to enhance patient monitoring and support by leveraging advanced information and communication technologies. With over 600,000 patients managed and more than 50 programs deployed, Voluntis emphasizes a patient-centric approach to healthcare, striving to improve medical outcomes and healthcare system efficiency through its digital health solutions.

Maeglin Software specializes in the development and marketing of innovative mobile Value Added Services for the telecommunications industry. The company focuses on creating peer-to-peer software solutions that facilitate the sharing of online mobile content and enable users to access and share backed-up contacts, pictures, videos, and documents via web and mobile internet. By prioritizing user data protection and cost control, Maeglin Software aims to enhance the mobile experience and empower individuals to manage their mobile lives more effectively.

Aldebaran Robotics, founded in 2005 and based in Paris, France, specializes in the design, manufacture, and sale of autonomous humanoid robots primarily for entertainment and assistance purposes. The company's notable products include NAO, a 58-cm tall humanoid robot designed to be a friendly companion capable of movement, recognition, auditory engagement, and conversation. Another key product, Pepper, is a social robot that interacts with humans, recognizes their emotions, and operates autonomously. Additionally, Romeo, a larger humanoid robot at 140 cm, is developed for research focused on assisting the elderly and individuals with reduced autonomy, featuring functionalities such as opening doors, climbing stairs, and grasping objects. Aldebaran Robotics aims to advance the field of humanoid robotics through innovative solutions that enhance human-robot interaction and support various applications in care and therapy.

Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT).

IntegraGen is a French biotechnology company located in the Genopole life science park in Evry, near Paris. The company focuses on the development of genetic biomarkers and offers a range of genomic and bioinformatic services. These services cater to the pharmaceutical industry, biotech firms, and various research institutions, encompassing clinical research, basic and human genetic research, bioinformatics, and bioanalysis. Additionally, IntegraGen provides solutions for agrigenomics and offers tools for microbiologic research, capitalizing on its unique intellectual property and research expertise.

OMNIlife science, Inc. specializes in the design, manufacture, and distribution of orthopedic devices, focusing on joint replacement solutions. Founded in 1999 and headquartered in East Taunton, Massachusetts, the company offers a range of products, including orthopedic implants for knees and hips, as well as advanced robotic navigation technology known as OMNINAV, which enhances the precision of total knee surgeries tailored to individual patients. The company serves a diverse international market, including regions such as South Africa, Switzerland, Turkey, and several European countries, distributing its products through various distributors. OMNIlife science operates as a subsidiary of Orthopaedic Synergy, Inc.

FittingBox, founded in 2006 by cousins Ariel Choukroun and Benjamin Hakoun, aims to enhance the eyewear shopping experience through innovative technology. The company has developed a virtual try-on solution that allows users to try on glasses in augmented reality, addressing the common challenge of visualizing how eyewear looks before making a purchase. By offering digital content that includes three-dimensional compression and face detection, FittingBox provides an interactive platform for eyecare professionals, helping customers find frames that complement their body type and personal style. This technology not only improves the customer experience but also supports businesses in the eyewear industry by streamlining the selection process.

Santen is a pharmaceutical company specializing in ophthalmic products, dedicated to improving the quality of life for patients worldwide. With over 120 years of research experience, Santen focuses primarily on the development of prescription ophthalmic pharmaceuticals, which constitutes the majority of its revenue. The company also offers over-the-counter medications and medical devices under its other operating segment. Santen's clinical development network spans Europe, Japan, and the United States, reflecting its commitment to addressing unmet needs in ophthalmology through innovative therapies and collaborative efforts. Most of its sales are generated in Japan, with a growing presence in other Asian markets.

Radio Systemes Ingenierie S.A. provides wireless communication systems. It offers Visioguard, a wireless alarm system that provide remote video monitoring, local monitoring with a TV or a monitor, integrated Internet-server, and emails with attached video-files. The company was founded in 2000 and is based in Strasbourg, France.

Anevia is a software company specializing in IPTV and over-the-top (OTT) video solutions, aimed at delivering live TV and video on demand (VOD) services across various devices, including TVs, PCs, and mobile devices. With a presence in over 70 countries and more than 1,000 deployments, Anevia supports millions of users and provides access to over 25,000 live channels. The company's offerings include advanced video compression, multiscreen IPTV headends, Cloud DVRs, and content delivery network (CDN) solutions, enabling the seamless delivery of high-quality video content, including 4K UHD, to diverse audiences. Anevia's technology is utilized by prominent telecom operators, broadcast service providers, and businesses in sectors such as hospitality and healthcare, reflecting its significant impact on the global video services market.

Stantum, Inc. designs and manufactures multitouch surface controllers. Its products include Lemur, which is a control surface for audio and media applications; and DEXTER, a laptop sized control surface, which is used for controlling digital audio workstations. The company’s products are used by musicians, composers, discjockies, media artists, researchers, and developers. It offers its products through distributors and retailers internationally. The company was formerly known as JazzMutant SAS and changed its name in 2007. Stantum, Inc. was founded in 2002 and is based in Bordeaux, France with a liaison office in Tokyo, Japan.

Novaled AG is a technology provider specializing in organic light-emitting diode (OLED) technologies, targeting the organic electronics market. Based in Dresden, Germany, and established in 2003, the company focuses on high-efficiency, long-lifetime OLED structures, leveraging its expertise in synthetic and analytical chemistry. Novaled offers complete solutions that include its proprietary Doping technology and materials, catering to customers in various sectors, including televisions and mobile devices. The company has built strong partnerships with major players in the OLED industry and holds a robust intellectual property portfolio, with over 500 patents granted or pending. Additionally, Novaled maintains branch offices in Asia to support its global operations.

Introduction to cacaoTV cacaoTV is a software that allows to view a streaming audio video media (i.e. TV channels) based on Peer to Peer (P2P) technology. cacaoTV works by using P2P technology, thus everyone when viewing media with cacaoweb client, the viewers upload content at the same time the programs are downloaded and viewed. cacaoweb creates a local stream on localhost and that stream is then read by Windows Media Player, Real Player or other media players. Since all viewers will upload content when viewing media, everyone becomes a broadcaster (server) without the cost of traditional streaming. And hence, the more users are online, the faster the programs can be loaded. And it will automatically find different connection nodes and download stream data from the nearest location (nodes). The good thing is, stream data is buffering in the memory, not on the hard disk. Channel Availability and Reliability Currently, most of the media contents are TV channels from the USA, and it includes some subscribers-based international channel such as HBO, ESPN, National Geographic and etc. Lately there are some independent channels that broadcast selective collection of media, such as latest blockbuster movies, collection of movies from a celebrity, or whole series of a drama. This kind of channels is created by individual viewers. There are also some radio channels available. Ease of Use and Speed of cacaoTV Just download cacaoweb and install it, and you’re ready to jump on the bandwagon of P2P TV. cacaoweb is able to work perfectly and stream smoothly without any configuration.

Crocus Technology SA specializes in magnetic random access memory products and technologies tailored for the semiconductor and electronic systems industries. The company develops magnetic sensors and embedded memory technology that facilitate efficient sensor data gathering and processing. Its products are designed for diverse applications, including telecommunications, networking, storage, computing, and handheld devices. Crocus Technology's innovative solutions enable fast read and write operations while maintaining a compact footprint, which enhances chip performance and security for devices such as smart cards, mobile phones, and data servers. By focusing on high sensitivity, stable temperature performance, and low power consumption, the company aims to improve productivity for its clients across various sectors.

TxCell S.A. is a biotechnology company based in Valbonne, France, specializing in the development of cellular immunotherapies utilizing regulatory T cells (Tregs) to address severe inflammatory and autoimmune diseases. The company's innovative therapies include TX200, a CAR-Treg-based treatment aimed at preventing graft rejection in solid organ transplantation. TxCell is also focused on developing CAR-Treg therapies for conditions such as bullous pemphigoid, multiple sclerosis, and refractory Crohn's disease, with ongoing clinical studies demonstrating promising results. The company collaborates with various research institutions, including the Lübeck Institute of Experimental Dermatology and the University of British Columbia, to enhance its research and development efforts. Additionally, TxCell is a subsidiary of Sangamo Therapeutics, having transitioned from its origins as a spin-off of Inserm, France's National Institute for Health and Medical Research.

EI-Technologies is a digital technology consulting firm based in Paris, France, established in 1994. The company specializes in IT consulting and internet software development services, offering a range of solutions including Salesforce implementations, workplace solutions branded as EI-Workplace, and training programs through EI-Institut focused on Salesforce technologies. EI-Technologies aims to enhance and optimize the technological and cloud-based processes of organizations by delivering comprehensive solutions that align with clients' strategic objectives. With a team of experts and a commitment to quality management, EI-Technologies supports clients in achieving digital efficiency and adopting innovative technologies. As of May 2020, the company operates as a subsidiary of Cognizant Technology Solutions Corporation.

Santaris Pharma A/S is a privately held clinical-stage biopharmaceutical company based in Denmark, specializing in the discovery and development of RNA-targeted therapies. Utilizing its proprietary Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine, the company focuses on delivering potent single-stranded LNA-based drug candidates for various disease states. Santaris Pharma's research and development efforts primarily target infectious diseases and cardiometabolic disorders, while also engaging in partnerships with major pharmaceutical companies to address a broader range of therapeutic areas, including cancer, cardiovascular disease, and rare genetic disorders. Founded in 2003, the company holds exclusive worldwide rights for the manufacture and sale of products containing LNA as an active ingredient, supporting its goal of obtaining marketing approval for its innovative therapies.

WIRECOM Technologies is a French company with state-of-the-art technology and an experience of over 10 years. Committed to sustainable development and the fight against global warming, WIRECOM Technologies designs and develops solutions to optimise energy efficiency in buildings and residences

Iwedia Technologies S.A., founded in 2004 and headquartered in Rennes, France, specializes in providing software solutions for connected audiovisual digital terminals. The company offers a range of services, including software engineering, system integration, user experience design, and product development. Iwedia focuses on delivering customized software components and engineering services throughout the digital image chain, enabling clients to develop cost-effective solutions for connected TV devices.

Aldebaran Robotics, founded in 2005 and based in Paris, France, specializes in the design, manufacture, and sale of autonomous humanoid robots primarily for entertainment and assistance purposes. The company's notable products include NAO, a 58-cm tall humanoid robot designed to be a friendly companion capable of movement, recognition, auditory engagement, and conversation. Another key product, Pepper, is a social robot that interacts with humans, recognizes their emotions, and operates autonomously. Additionally, Romeo, a larger humanoid robot at 140 cm, is developed for research focused on assisting the elderly and individuals with reduced autonomy, featuring functionalities such as opening doors, climbing stairs, and grasping objects. Aldebaran Robotics aims to advance the field of humanoid robotics through innovative solutions that enhance human-robot interaction and support various applications in care and therapy.

Citilog S.A. specializes in video-based real-time monitoring and surveillance solutions for the transportation sector. The company develops advanced Automatic Incident Detection systems that quickly identify incidents on highways, bridges, and tunnels, enhancing safety and operational efficiency. Its product offerings include MediaCity, which detects vehicle presence and queues while providing traffic data, and MediaManager, a comprehensive software platform for traffic and incident management. Additionally, Citilog provides various sensors for intersection control and monitoring, including license plate recognition and hazardous goods detection systems. These tools support effective road transportation management in smart cities and contribute to improved road safety and mobility. Founded in 1997 and headquartered in Arcueil, France, Citilog also maintains offices in Bala Cynwyd, Pennsylvania; Valencia, Spain; and Wanchai, Hong Kong. The company distributes its products through a network of value-added resellers and distributors globally.

Crocus Technology SA specializes in magnetic random access memory products and technologies tailored for the semiconductor and electronic systems industries. The company develops magnetic sensors and embedded memory technology that facilitate efficient sensor data gathering and processing. Its products are designed for diverse applications, including telecommunications, networking, storage, computing, and handheld devices. Crocus Technology's innovative solutions enable fast read and write operations while maintaining a compact footprint, which enhances chip performance and security for devices such as smart cards, mobile phones, and data servers. By focusing on high sensitivity, stable temperature performance, and low power consumption, the company aims to improve productivity for its clients across various sectors.

Nemoptic, an epaper display company, designs and manufactures superior-quality bistable liquid crystal displays (LCD) modules highly suitable for consumer and professional mobile devices.

Santen is a pharmaceutical company specializing in ophthalmic products, dedicated to improving the quality of life for patients worldwide. With over 120 years of research experience, Santen focuses primarily on the development of prescription ophthalmic pharmaceuticals, which constitutes the majority of its revenue. The company also offers over-the-counter medications and medical devices under its other operating segment. Santen's clinical development network spans Europe, Japan, and the United States, reflecting its commitment to addressing unmet needs in ophthalmology through innovative therapies and collaborative efforts. Most of its sales are generated in Japan, with a growing presence in other Asian markets.

Iwedia Technologies S.A., founded in 2004 and headquartered in Rennes, France, specializes in providing software solutions for connected audiovisual digital terminals. The company offers a range of services, including software engineering, system integration, user experience design, and product development. Iwedia focuses on delivering customized software components and engineering services throughout the digital image chain, enabling clients to develop cost-effective solutions for connected TV devices.

WIRECOM Technologies is a French company with state-of-the-art technology and an experience of over 10 years. Committed to sustainable development and the fight against global warming, WIRECOM Technologies designs and develops solutions to optimise energy efficiency in buildings and residences

Novaled AG is a technology provider specializing in organic light-emitting diode (OLED) technologies, targeting the organic electronics market. Based in Dresden, Germany, and established in 2003, the company focuses on high-efficiency, long-lifetime OLED structures, leveraging its expertise in synthetic and analytical chemistry. Novaled offers complete solutions that include its proprietary Doping technology and materials, catering to customers in various sectors, including televisions and mobile devices. The company has built strong partnerships with major players in the OLED industry and holds a robust intellectual property portfolio, with over 500 patents granted or pending. Additionally, Novaled maintains branch offices in Asia to support its global operations.

Graitec Group is a software development company specializing in Building Information Modeling (BIM) and computer-aided design (CAD) solutions for the architecture, engineering, and construction (AEC) industry. Founded in 1986, Graitec operates across 29 offices in 12 countries, serving over 40,000 construction professionals globally. The company is recognized as an Autodesk Platinum Partner and provides a comprehensive range of software, including Graitec Advance, which streamlines the structural design and construction documentation process. This technology automates key tasks such as engineering design, structural analysis, member optimization, detailing, and fabrication. Graitec's solutions enhance collaboration among project stakeholders, improve communication, and enable efficient project management through features like automatic document creation and project tracking. The firm's focus on innovation and quality positions it as a leader in delivering high-performance BIM solutions that meet the evolving demands of the construction industry.

Iwedia Technologies S.A., founded in 2004 and headquartered in Rennes, France, specializes in providing software solutions for connected audiovisual digital terminals. The company offers a range of services, including software engineering, system integration, user experience design, and product development. Iwedia focuses on delivering customized software components and engineering services throughout the digital image chain, enabling clients to develop cost-effective solutions for connected TV devices.

Ipracom SA, based in Massy, France, specializes in the development of software solutions for personal digital assistants (PDAs) and smartphones. The company offers products such as Ipra*Cool and Ipra*PC, which facilitate connectivity between mobile devices and personal computers, allowing users to access files and check email. In addition to these offerings, Ipracom develops software tailored for specific vertical applications. The company's clients include notable telecommunications firms such as Orange, Bouygues Telecom, and Smart Communications. Ipracom became a subsidiary of Maeglin Software in 2007.

Zealand Pharma A/S is a biotechnology company based in Copenhagen, Denmark, specializing in the discovery and development of peptide-based medicines. The company has a growing proprietary pipeline that includes several clinical candidates such as glepaglutide for short bowel syndrome and dasiglucagon for diabetes management and congenital hyperinsulinism. Zealand's first developed medicine, lixisenatide, is a once-daily GLP-1 analogue for Type 2 diabetes, marketed globally outside the US. The company has established collaborations with major pharmaceutical partners, including Sanofi, Helsinn Healthcare, and Boehringer Ingelheim, enhancing its product offerings and expanding its reach in the market. Zealand Pharma is committed to advancing innovative therapies, with multiple projects in various stages of clinical development and preclinical research.

Kuros Biosciences AG is a biopharmaceutical company based in Schlieren, Switzerland, dedicated to the discovery, development, and commercialization of innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off from the Eidgenössische Technische Hochschule Zürich, Kuros has developed a robust pipeline of biopharmaceuticals targeting chronic diseases. Its key products include Neuroseal, a novel biomaterial for dural sealing, and the MagnetOs family of bone graft substitutes used in orthopedic, spinal, and dental applications. MagnetOs is approved for use in the EU and the US, with further formulations under development for regulatory submission. Kuros also has a range of clinical-stage products, including KUR-111 and KUR-113, which have completed Phase II clinical trials for treating specific bone fractures. The company has engaged in significant clinical research, enrolling over 600 patients in multinational trials, generating promising data regarding safety and efficacy in various applications, particularly within orthobiologics.

Radio Systemes Ingenierie S.A. provides wireless communication systems. It offers Visioguard, a wireless alarm system that provide remote video monitoring, local monitoring with a TV or a monitor, integrated Internet-server, and emails with attached video-files. The company was founded in 2000 and is based in Strasbourg, France.

Santen is a pharmaceutical company specializing in ophthalmic products, dedicated to improving the quality of life for patients worldwide. With over 120 years of research experience, Santen focuses primarily on the development of prescription ophthalmic pharmaceuticals, which constitutes the majority of its revenue. The company also offers over-the-counter medications and medical devices under its other operating segment. Santen's clinical development network spans Europe, Japan, and the United States, reflecting its commitment to addressing unmet needs in ophthalmology through innovative therapies and collaborative efforts. Most of its sales are generated in Japan, with a growing presence in other Asian markets.

RocTool S.A. is a technology and manufacturing solutions provider based in Le Bourget du Lac, France. The company specializes in induction heating systems and tooling hardware for injection and compression molding, serving various industries including automotive, consumer electronics, aerospace, and medical markets. RocTool offers a range of products such as generators, cooling units, and interfaces, along with engineering and installation services. The company's innovative technologies, including IDH™ (Induction Dual Heating), enhance product performance, reduce cycle times, and improve surface quality. RocTool's research and development efforts focus on adapting induction technologies to a wider array of materials, contributing to overall cost reductions and lightweighting solutions. The company has a global presence with offices in North America, Japan, Taiwan, and Germany, and it also licenses its molding technologies to various sectors.

Santen is a pharmaceutical company specializing in ophthalmic products, dedicated to improving the quality of life for patients worldwide. With over 120 years of research experience, Santen focuses primarily on the development of prescription ophthalmic pharmaceuticals, which constitutes the majority of its revenue. The company also offers over-the-counter medications and medical devices under its other operating segment. Santen's clinical development network spans Europe, Japan, and the United States, reflecting its commitment to addressing unmet needs in ophthalmology through innovative therapies and collaborative efforts. Most of its sales are generated in Japan, with a growing presence in other Asian markets.

TheraDiag is a France-based company specializing in the development, manufacturing, and marketing of in-vitro diagnostic products. Founded in 1986 and headquartered in Marne La Vallée, the company offers a range of diagnostic tools, including reagents for autoimmune and infectious diseases, as well as fertility tests. Notable products include IMMUNO-TROL, a quality control tool; various instruments for disease testing; and the SQA-V semen analyzer. TheraDiag also provides advanced instrumentation such as the Theralis platform, which integrates immunofluorescence and ELISA technologies, and the FIDIS platform for laboratory analysis. Additionally, the company offers therapeutic drug monitoring services for chronic inflammatory diseases and LISA tracker, a tool designed for monitoring biotherapies.

Teem Photonics S.A., based in Meylan, France, specializes in the manufacture and sale of passively Q-switched microlasers and photonics integrated circuits utilizing ion-exchange technology. The company’s microlasers are known for generating sub-nanosecond, high peak power pulses in compact packages at high repetition rates, making them suitable for various industrial applications. Teem Photonics also provides a range of products including infrared, green, and ultraviolet lasers, along with advanced integrated optics solutions for fields such as biomedical, marking, sensing, and material processing. Additionally, the company offers custom integrated optics devices, optical design, foundry services, and technical support. Established in 1998, Teem Photonics has expanded its operations globally, with offices in Europe, Asia and the Pacific, North America, and Mexico.

Kuros Biosciences AG is a biopharmaceutical company based in Schlieren, Switzerland, dedicated to the discovery, development, and commercialization of innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off from the Eidgenössische Technische Hochschule Zürich, Kuros has developed a robust pipeline of biopharmaceuticals targeting chronic diseases. Its key products include Neuroseal, a novel biomaterial for dural sealing, and the MagnetOs family of bone graft substitutes used in orthopedic, spinal, and dental applications. MagnetOs is approved for use in the EU and the US, with further formulations under development for regulatory submission. Kuros also has a range of clinical-stage products, including KUR-111 and KUR-113, which have completed Phase II clinical trials for treating specific bone fractures. The company has engaged in significant clinical research, enrolling over 600 patients in multinational trials, generating promising data regarding safety and efficacy in various applications, particularly within orthobiologics.

Drug Abuse Sciences develops and commercializes therapies for the treatment of alcohol and drug addictions. It offers Naltrexone Depot, a sustained-release formulation of Naltrexone for the treatment of alcohol and opiate addictions; DAS-431 for the treatment of cocaine addiction; and Buprenorphine Depot, a sustained-release formulation of buprenorphine for the treatment of heroin and various opiate addictions. Drug Abuse Sciences is based in Menlo Park, California.

TheraDiag is a France-based company specializing in the development, manufacturing, and marketing of in-vitro diagnostic products. Founded in 1986 and headquartered in Marne La Vallée, the company offers a range of diagnostic tools, including reagents for autoimmune and infectious diseases, as well as fertility tests. Notable products include IMMUNO-TROL, a quality control tool; various instruments for disease testing; and the SQA-V semen analyzer. TheraDiag also provides advanced instrumentation such as the Theralis platform, which integrates immunofluorescence and ELISA technologies, and the FIDIS platform for laboratory analysis. Additionally, the company offers therapeutic drug monitoring services for chronic inflammatory diseases and LISA tracker, a tool designed for monitoring biotherapies.

6Wind S.A. specializes in designing and developing high-performance networking software for a diverse clientele, including individual developers, Fortune 500 companies, and the telecommunications sector. The company offers a range of solutions such as network function virtualization, software-defined networking, and various security applications. Notable products include 6WINDGate, a packet processing software enabling large-scale deployment of high-performance networks, and the 6WIND Virtual Accelerator, which enhances virtual infrastructures. Additional offerings include the Turbo Router, suitable for both bare metal and virtual environments, and secure site-to-site VPN solutions for data center interconnection. Founded in 2000 and headquartered in Montigny-le-Bretonneux, France, with offices in the United States, China, Japan, and South Korea, 6Wind is recognized as a market leader in vRouter solutions, allowing clients to optimize operations and reduce costs through software-based virtualization.

Santen is a pharmaceutical company specializing in ophthalmic products, dedicated to improving the quality of life for patients worldwide. With over 120 years of research experience, Santen focuses primarily on the development of prescription ophthalmic pharmaceuticals, which constitutes the majority of its revenue. The company also offers over-the-counter medications and medical devices under its other operating segment. Santen's clinical development network spans Europe, Japan, and the United States, reflecting its commitment to addressing unmet needs in ophthalmology through innovative therapies and collaborative efforts. Most of its sales are generated in Japan, with a growing presence in other Asian markets.